Skip to main content
SpringerLink
Log in

Alpha-fetoprotein and human telomerase reverse transcriptase mRNA levels in peripheral blood of patients with hepatocellular carcinoma

  • Original Paper
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

Purpose

Tumor-associated gene expression in peripheral blood reflects the presence of circulating hepatocellular carcinoma (HCC) cells and might be associated with aggressive features of HCC. We assessed the prognostic significance of alpha-fetoprotein (AFP) and human telomerase reverse transcriptase protein (hTERT) mRNA expression in the peripheral blood of HCC patients.

Methods

About 343 HCC patients, treated at the National Cancer Center, Korea, were included in this study. We measured AFP and hTERT mRNA levels in peripheral blood using quantitative real-time reverse transcription polymerase chain reaction. The association between the expression of each gene and survival was analyzed.

Results

AFP and hTERT mRNA were detected in 204 (59.5%) and 48 (14.0%) patients with HCC, respectively. The mean AFP copy number was 203 copies/μL (range 0–19992 copies/μL) and that of hTERT was 26 copies/μL (0–1711 copies/μL). AFP mRNA expression was correlated with the number of tumors (P = 0.05), but there were no significant association between hTERT expression and clinical features. There was also no relationship between overall survival and AFP (P = 0.08) or hTERT (P = 0.67) mRNA expression.

Conclusions

This is the first report to evaluate the association between peripheral blood hTERT mRNA expression, and survival of HCC patients. The results indicate that AFP and hTERT mRNA expression in peripheral blood may not be useful HCC prognostic markers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Bruix J, Sherman M (2005) Management of hepatocellular carcinoma. Hepatology 42:1208–1236. doi:10.1002/hep.20933

    Article  PubMed  Google Scholar 

  • Cillo U, Navaglia F, Vitale A, Molari A, Basso D, Bassanello M, Brolese A, Zanus G, Montin U, D’Amico F, Ciarleglio FA, Carraro A, Bridda A, Burra P, Carraro P, Plebani M, D’Amico DF (2004) Clinical significance of alpha-fetoprotein mRNA in blood of patients with hepatocellular carcinoma. Clin Chim Acta 347:129–138. doi:10.1016/j.cccn.2004.04.032

    Article  PubMed  CAS  Google Scholar 

  • El-Serag HB, Siegel AB, Davila JA, Shaib YH, Cayton-Woody M, McBride R, McGlynn KA (2006) Treatment and outcomes of treating of hepatocellular carcinoma among medicare recipients in the United States: a population-based study. J Hepatol 44:158–166. doi:10.1016/j.jhep.2005.10.002

    Article  PubMed  Google Scholar 

  • Funaki N, Tanaka J, Seto S, Kasamatsu T, Kaido T, Imamura M (1995) Highly-sensitive identification of alpha-fetoprotein mRNA in circulating peripheral blood of hepatocellular carcinoma patients. Life Sci 57:1621–1631. doi:10.1016/0024-3205(95)02138-9

    Article  PubMed  CAS  Google Scholar 

  • Funaki NO, Tanaka J, Seto SI, Kasamatsu T, Kaido T, Imamura M (1997) Hematogenous spreading of hepatocellular carcinoma cells: possible participation in recurrence in the liver. Hepatology 25:564–568. doi:10.1002/hep.510250312

    Article  PubMed  CAS  Google Scholar 

  • Gross-Goupil M, Saffroy R, Azoulay D, Precetti S, Emile JF, Delvart V, Tindiliere F, Laurent A, Bellin MF, Bismuth H, Debuire B, Lemoine A (2003) Real-time quantification of AFP mRNA to assess hematogenous dissemination after transarterial chemoembolization of hepatocellular carcinoma. Ann Surg 238:241–248

    PubMed  Google Scholar 

  • Lechel A, Manns MP, Rudolph KL (2004) Telomeres and telomerase: new targets for the treatment of liver cirrhosis and hepatocellular carcinoma. J Hepatol 41:491–497. doi:10.1016/j.jhep.2004.06.010

    Article  PubMed  CAS  Google Scholar 

  • Lemoine A, Le Bricon T, Salvucci M, Azoulay D, Pham P, Raccuia J, Bismuth H, Debuire B (1997) Prospective evaluation of circulating hepatocytes by alpha-fetoprotein mRNA in humans during liver surgery. Ann Surg 226:43–50. doi:10.1097/00000658-199707000-00006

    Article  PubMed  CAS  Google Scholar 

  • Louha M, Poussin K, Ganne N, Zylberberg H, Nalpas B, Nicolet J, Capron F, Soubrane O, Vons C, Pol S, Beaugrand M, Berthelot P, Franco D, Trinchet JC, Brechot C, Paterlini P (1997) Spontaneous and iatrogenic spreading of liver-derived cells into peripheral blood of patients with primary liver cancer. Hepatology 26:998–1005. doi:10.1002/hep.510260430

    Article  PubMed  CAS  Google Scholar 

  • Miura N, Shiota G, Nakagawa T, Maeda Y, Sano A, Marumoto A, Kishimoto Y, Murawaki Y, Hasegawa J (2003) Sensitive detection of human telomerase reverse transcriptase mRNA in the serum of patients with hepatocellular carcinoma. Oncology 64:430–434. doi:10.1159/000070303

    Article  PubMed  CAS  Google Scholar 

  • Miura N, Maeda Y, Kanbe T, Yazama H, Takeda Y, Sato R, Tsukamoto T, Sato E, Marumoto A, Harada T, Sano A, Kishimoto Y, Hirooka Y, Murawaki Y, Hasegawa J, Shiota G (2005) Serum human telomerase reverse transcriptase messenger RNA as a novel tumor marker for hepatocellular carcinoma. Clin Cancer Res 11:3205–3209. doi:10.1158/1078-0432.CCR-04-1487

    Article  PubMed  CAS  Google Scholar 

  • Mozdy AD, Cech TR (2006) Low abundance of telomerase in yeast: implications for telomerase haploinsufficiency. RNA 12:1721–1737. doi:10.1261/rna.134706

    Article  PubMed  CAS  Google Scholar 

  • Park J (2004) Practice guideline for diagnosis and treatment of hepatocellular carcinoma. Korean J Hepatol 10:88–98

    PubMed  Google Scholar 

  • Park KW, Park JW, Choi JI, Kim TH, Kim SH, Park HS, Lee WJ, Park SJ, Hong EK, Kim CM (2008) Survival analysis of 904 patients with hepatocellular carcinoma in a hepatitis B virus-endemic area. J Gastroenterol Hepatol 23:467–473. doi:10.1111/j.1440-1746.2007.05112.x

    Article  PubMed  Google Scholar 

  • Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108

    Article  PubMed  Google Scholar 

  • Sato S, Noguchi Y, Wada H, Fujita S, Nakamura S, Tanaka R, Nakada T, Hasegawa K, Nakagawa K, Koizumi F, Ono T, Nouso K, Jungbluth A, Chen YT, Old LJ, Shiratori Y, Nakayama E (2005) Quantitative real-time RT-PCR analysis of NY-ESO-1 and LAGE-1a mRNA expression in normal tissues and tumors, and correlation of the protein expression with the mRNA copy number. Int J Oncol 26:57–63

    PubMed  CAS  Google Scholar 

  • Tung-Ping Poon R, Fan ST, Wong J (2000) Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 232:10–24. doi:10.1097/00000658-200007000-00003

    Article  PubMed  CAS  Google Scholar 

  • Ueno S, Tanabe G, Nuruki K, Hamanoue M, Komorizono Y, Oketani M, Hokotate H, Inoue H, Baba Y, Imamura Y, Aikou T (2002) Prognostic performance of the new classification of primary liver cancer of Japan (4th ed) for patients with hepatocellular carcinoma: a validation analysis. Hepatol Res 24:395–403. doi:10.1016/S1386-6346(02)00144-4

    Article  PubMed  Google Scholar 

  • Waguri N, Suda T, Nomoto M, Kawai H, Mita Y, Kuroiwa T, Igarashi M, Kobayashi M, Fukuhara Y, Aoyagi Y (2003) Sensitive and specific detection of circulating cancer cells in patients with hepatocellular carcinoma; detection of human telomerase reverse transcriptase messenger RNA after immunomagnetic separation. Clin Cancer Res 9:3004–3011

    PubMed  CAS  Google Scholar 

  • Witzigmann H, Geissler F, Benedix F, Thiery J, Uhlmann D, Tannapfel A, Wittekind C, Hauss J (2002) Prospective evaluation of circulating hepatocytes by alpha-fetoprotein messenger RNA in patients with hepatocellular carcinoma. Surgery 131:34–43. doi:10.1067/msy.2002.118954

    Article  PubMed  Google Scholar 

  • Wong IH, Yeo W, Leung T, Lau WY, Johnson PJ (2001) Circulating tumor cell mRNAs in peripheral blood from hepato cellular carcinoma patients under radiotherapy, surgical resection or chemotherapy: a quantitative evaluation. Cancer Lett 167:183–191. doi:10.1016/S0304-3835(01)00455-4

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported solely by the National Cancer Center Grant 0810260.

Author information

Authors and Affiliations

  1. Center for Clinical Services, Department of Laboratory Medicine, Research Institute and Hospital, National Cancer Center, 809 Madu 1-dong, Ilsandong-gu, Goyang, Gyeonggi, 410-769, Republic of Korea

    Sun-Young Kong

  2. Center for Liver Cancer, Research Institute and Hospital, National Cancer Center, 809 Madu 1-dong, Ilsandong-gu, Goyang, Gyeonggi, 410-769, Republic of Korea

    Joong-Won Park, Jin Oak Kim, Nam Oak Lee, Jung An Lee, Eun Kyung Hong & Chang-Min Kim

  3. Center for Cancer Prevention and Detection, Research Institute and Hospital, National Cancer Center, 809 Madu 1-dong, Ilsandong-gu, Goyang, Gyeonggi, 410-769, Republic of Korea

    Kyung Woo Park

Authors
  1. Sun-Young Kong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joong-Won Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jin Oak Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nam Oak Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jung An Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kyung Woo Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Eun Kyung Hong
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Chang-Min Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joong-Won Park.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kong, SY., Park, JW., Kim, J.O. et al. Alpha-fetoprotein and human telomerase reverse transcriptase mRNA levels in peripheral blood of patients with hepatocellular carcinoma. J Cancer Res Clin Oncol 135, 1091–1098 (2009). https://doi.org/10.1007/s00432-009-0549-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-009-0549-9

Keywords

Search

Navigation